v3.19.3

Note 5 - Other Balance Sheet Information

6 Months Ended

Jun. 30, 2019

Notes to Financial Statements

Supplemental Balance Sheet Disclosures [Text Block]

Note 5.   Other Balance Sheet Information

Prepaid and other current assets consist of the following (in thousands):

		December 31, 2018			June 30, 2019
Prepaid clinical trial expenses		$	5		$	435
Equity issuance costs		—			343
Prepaid insurance		—			670
Other prepaid expenses		5			174
Total prepaid and other current assets		$	10		$	1,622

Accrued liabilities consist of the following (in thousands):

		December 31, 2018			June 30, 2019
Payroll and related expenses		$	241		$	508
Accrued term loan final payment		421			569
Accrued clinical trial expense		—			8
Professional fees and other costs		195			395
Total accrued liabilities		$	857		$	1,480

X

- References

No definition available.

+ Details

Name:	us-gaap_DisclosureTextBlockAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

The entire disclosure for supplemental balance sheet disclosures, including descriptions and amounts for assets, liabilities, and equity.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-URI http://asc.fasb.org/topic&trid=2122208

+ Details

Name:	us-gaap_SupplementalBalanceSheetDisclosuresTextBlock
Namespace Prefix:	us-gaap_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration